A study to assess the drug absorption into the blood after administration of 3 doses of AZD5718

Study identifier:D7550C00009

ClinicalTrials.gov identifier:NCT04087187

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Randomized, 3-period, 3-treatment, Single-dose, Open-label, Single-center, Crossover Study to Assess the Pharmacokinetics of 3 Doses of AZD5718

Medical condition

Coronary artery disease

Phase

Phase 1

Healthy volunteers

Yes

Study drug

Treatment A, Treatment A, Treatment A, Treatment A, Treatment A, Treatment A, Treatment B, Treatment B, Treatment B, Treatment B, Treatment B, Treatment B, Treatment C, Treatment C, Treatment C, Treatment C, Treatment C, Treatment C

Sex

All

Actual enrollment

14

Study type

Interventional

Age

18 Years - 55 Years

Date

Study Start Date: 20 Sept 2019
Primary Completion Date: 31 Oct 2019
Study Completion Date: 31 Oct 2019

Study design

Allocation: Randomized
Endpoint Classification: -
Intervention Model: Crossover Assignment
Masking: -
Primary Purpose: Treatment

Verification:

Verified 01 Apr 2020 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

PAREXEL

Inclusion and exclusion criteria